| CTRI Number |
CTRI/2025/08/093202 [Registered on: 18/08/2025] Trial Registered Prospectively |
| Last Modified On: |
26/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Effect of drink before surgery on blood glucose in diabetic patients |
|
Scientific Title of Study
|
Effect of preoperative oral carbohydrate on perioperative blood glucose in Indian patients with type 2 diabetes mellitus scheduled for surgery under general anaesthesia - a randomized controlled study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vishal Sharma |
| Designation |
Post graduate student |
| Affiliation |
University college of medical sciences |
| Address |
Dept. of anaesthesiology and critical care
university college of medical sciences and guru teg bahadur hospital
dilshad garden , new delhi
North East DELHI 110095 India |
| Phone |
9643514385 |
| Fax |
|
| Email |
drvishalsharma9997@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
RS Rautela |
| Designation |
Director Professor |
| Affiliation |
University college of medical sciences |
| Address |
Department of anaesthesiology and critical care
university college of medical sciences
dilshad garden , new delhi
North East DELHI 110095 India |
| Phone |
9868399699 |
| Fax |
|
| Email |
rsramb@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Vishal Sharma |
| Designation |
post graduate student |
| Affiliation |
University college of medical sciences |
| Address |
dept. of anaesthesiology and critical care
university college of medical sciences
dilshad garden,new delhi
North East DELHI 110095 India |
| Phone |
9643514385 |
| Fax |
|
| Email |
drvishalsharma9997@gmail.com |
|
|
Source of Monetary or Material Support
|
| University College of Medical Sciences Dilshad Garden
Delhi 110095 |
|
|
Primary Sponsor
|
| Name |
university college of medical sciences |
| Address |
University college of medical sciences
dilshad garden
new delhi |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DRVISHAL SHARMA |
Guru Teg Bahadur Hospital Dilshad Garden Delhi |
Main ICU
Second Floor OT Block
Department of Anaesthesia
Dilshad Garden
Delhi North East DELHI |
09643514383
drvishalsharma9997@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee- Human Research |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Energizer drink will be given |
In group A patients 296 ml of energizer drink will be given 2 h before surgery |
| Intervention |
Preoperative drink will be given |
All patients will receive either preoperative oral carbohydrate drink or plain drinking water 2 h before the surgery |
| Comparator Agent |
Water will be given |
In group B patients 296 ml of plain drinking water will be given 2 h before surgery |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
Patients older than 18 years with type II diabetes, with HbA1c less than 7 (within last month) and fasting blood glucose on the morning of surgery within 80-180 mg/dL scheduled for elective surgery under general anaesthesia will be included. |
|
| ExclusionCriteria |
| Details |
Patients with any of the following will be excluded:
1.Known case of T1DM, Type II DM requiring insulin therapy, pheochromocytoma, carcinoid tumor etc.
2.H/o pancreatitis, alcoholism, jaundice or liver disorders
3.Obesity (BMI more than 30 kg/m2)
4.Patients with history of gastro-oesophageal reflux, gastric outlet/intestinal obstruction, emergency surgery, pregnant females
5.Patients on continuous steroid therapy for more than 5 days in the last one year.
6.Unwilling to participate in the study |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Blood Glucose level |
Once, 2 hours after preoperative drink |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Perioperative glucose control |
|
| Insulin level |
T0-fasting serum insulin levels
T1-2 hours after water/carbohydrate drink
T24-24 hours after the surgery |
| Insulin resistance |
T0-fasting
T1-2 hours after water/carbohydrate drink
T24-24 hours after the surgery |
| Post operative nausea and vomiting |
0-2 hours
2-6 hours
6-24 hours |
| Post-surgery recovery pattern |
|
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
18/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Patients undergoing elective surgery are subjected to prolonged period of fasting in view of risk of pulmonary aspiration. Preoperative fasting state leads to a catabolic state, which adds to patient discomfort and delayed mobilization. Prolonged fasting and surgical trauma enhance the release of stress hormone, which leads to the development of hyperglycemia and insulin resistance (IR). Preoperative oral carbohydrate (POC) has shown beneficial effects in postoperative patient outcome and in decreasing hyperglycemia and IR. But, the effect of POC administration in Indian patients with Type 2 diabetes mellitus (DM) still remains inconclusive. Therefore, in this study we aim to see the effect of preoperative oral carbohydrate on perioperative blood glucose in Indian patients with Type 2 DM scheduled for surgery under general anaesthesia. The study will be conducted after obtaining approval from Institutional Ethics Committee-Human Research and written and informed consent. Patient will be asked to omit oral hypoglycemic agents as routinely done before surgery. Last meal time will be noted for all the patients. An independent anaesthesiologist not involved in the further management of the patient will administer the carbohydrate drink/water as per group allocation based on a computer generated table of random numbers. Group A: Patients in this group will remain nil per orally for solids for at least 6 hours and will receive 296 ml drinking water 2 hrs before surgery. Group B: Patients in this group will remain nil per orally for solids for at least 6 hours and will receive 296 ml of oral carbohydrate solution containing 50g maltodextrin (Energizer-Neon laboratories) 2 hours before surgery. Patients will be taken inside the operating room where routine monitoring will be initiated. General anaesthesia will be given and the surgery will be allowed to proceed. Hourly glucose measurements will be done (capillary blood glucose). Blood samples will be collected for the estimation of serum insulin for the calculation of insulin resistance. Intraoperatively insulin will be administered as per Vellore regime to maintain blood glucose <180 mg/dL. |